Why the study?
Does FFR-guided PCI improve outcomes in patients with stable coronary artery disease compared to medical therapy alone?
Does FFR-guided PCI improve outcomes in patients with stable coronary artery disease compared to medical therapy alone?
In patients with stable coronary artery disease, FFR-guided PCI improves outcomes compared to medical therapy alone, whereas patients without ischemia have favorable outcomes with medical therapy alone.
Supports FFR-guided PCI in stable CAD with ischemia; confirms benefit of physiology-driven revascularization over medical therapy.
In patients with stable coronary artery disease, FFR-guided PCI, as compared with medical therapy alone, improved the outcome. Patients without ischemia had a favorable outcome with medical therapy alone. (Funded by St. Jude Medical; FAME 2 ClinicalTrials.gov number, NCT01132495.).
No takes yet. Share an insight, caveat, or question.
Bruyne et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: